Phase III process development and control

Proving Readiness for Commercial Scale

We help you define, demonstrate, and document control, aligning science, data, and strategy to achieve process validation and regulatory approval.

Phase III Process Development and Control
Quick filter:

At Phase III, the goal shifts to validation. Every parameter, limit, and control strategy must be demonstrated, justified, and ready to withstand regulatory and commercial scrutiny.

We ensure that your process is not only efficient, but scientifically defensible – built on complete understanding, reproducible performance, and validated analytics.

We bring together process chemistry, analytical excellence, and data-driven governance to deliver a process that’s ready for technology transfer, validation, and commercial production. Our work strengthens the scientific foundation that underpins every successful registration and launch.

How We Support You
Define and Confirm the Control Strategy
Finalise critical process parameters (CPPs) and control limits through QbD and statistical validation.
Demonstrate Process Robustness
Conduct validation-scale studies, reproducibility assessments, and comparability demonstrations.
Validate Analytical Methods
Finalise analytical methods for validation and release, aligned with ICH Q14 and regulatory expectations.
Support Registration and Tech Transfer
Deliver complete CMC documentation, risk assessments, and validation packages for authority review.
Sustain Quality and Compliance
Ensure process capability and lifecycle management plans are in place for commercial production.

Our Core, Phase III Capabilities

Process Validation & Control

• Design of experiments (DoE) and multivariate analysis for CPP confirmation
• Process reproducibility and validation batch execution
• Statistical evaluation of process capability and control limits
• Lifecycle management planning for continued verification

Analytical Validation & Compliance

• Method validation, robustness, and transfer to commercial QC
• Reference standard qualification and impurity specification control
• Data integrity and traceability assurance
• Regulatory documentation and response support

Technology Transfer & Commercial Readiness

• Preparation of process validation and tech transfer documentation
• GMP demonstration batches and comparability studies
• Collaboration with manufacturing partners to enable smooth validation runs
• Sustainability and continuous improvement recommendations for long-term control

Regulatory & Quality Governance

• CMC authoring and validation documentation for NDA/MAA filings
• Preparation for pre-approval inspections and QA readiness reviews
• Risk-based justifications and CAPA frameworks
• Authority liaison and response strategy

Led by Our Teams
Our Therapeutic Modalities
Therapeutic Modalities
Small Molecules
Our small molecule scientists design and optimise scalable, efficient routes that balance innovation with manufacturability. Our expertise spans route scouting, process chemistry, solid-state science, and HPAPI development, delivering chemistry that performs from lab to launch.
Explore more
Therapeutic Modalities
Oligonucleotides
Our oligonucleotide experts unite chemistry and analytics to accelerate RNA-based therapeutics. From sequence design to conjugation, they deliver decision-ready data and scalable solutions for siRNA, ASO, and emerging nucleic acid platforms.
Explore more
Therapeutic Modalities
Peptides
Specialists in complex peptide synthesis, modification, and purification, our team create high-quality linear, cyclic, and stapled peptides. They combine deep chemical insight with analytical rigour to deliver stability, purity, and performance in every sequence.
Explore more
Therapeutic Modalities
TACs and Glues
Our targeted protein degradation scientists bring together expertise in bifunctional design, linker chemistry, and biological testing. They turn complexity into robust process understanding - engineering degraders and molecular glues that are stable, scalable, and ready for development.
Explore more
Therapeutic Modalities
Hybrid Modalities
At the intersection of chemistry and biology, our hybrid modality scientists develop conjugates and multifunctional platforms that expand the therapeutic potential of these molecules. Our integrated approach ensures structural control, stability, and delivery across modalities.
Explore more
Therapeutic Modalities
Complex Synthetic Medicines
Our scientists excel at bridging modalities, integrating small molecule, peptide, and oligonucleotide expertise to develop hybrid constructs and next-generation therapeutics. They thrive on solving the challenges that sit at the edges of chemistry and biology.
Explore more

What This Stage Enables for Your Programme

At this stage, your process becomes a validated system. Our integrated approach ensures it performs consistently and predictably, delivering compliant, reproducible results ready for commercial manufacture and inspection. With robust documentation and seamless technology transfer, you move forward knowing your CMC package can withstand the highest level of regulatory scrutiny.

Why It’s Different Working With Us

Scientific Rigour with a Commercial Focus
Every study is designed to prove, not just to show.
Regulatory Readiness Built In
Documentation and data structured for global filings.
Built for Collaboration
We integrate seamlessly with your CDMO, CMO, or internal teams.
Future-Proofed Processes
Control strategies designed for lifecycle management and continuous verification.
1 / 1
“Phase III is where process science becomes commercial reality. We make sure every parameter, document, and dataset stands up to validation and inspection.”
Rob Crook
Director of Chemical Sciences

Book a Consultation

Speak directly with our scientists about your development challenges and see how we can support your program.